GB0216972D0 - Peptides and peptide derivaties for the treatment of &-synuclein-related diseases - Google Patents
Peptides and peptide derivaties for the treatment of &-synuclein-related diseasesInfo
- Publication number
- GB0216972D0 GB0216972D0 GB0216972A GB0216972A GB0216972D0 GB 0216972 D0 GB0216972 D0 GB 0216972D0 GB 0216972 A GB0216972 A GB 0216972A GB 0216972 A GB0216972 A GB 0216972A GB 0216972 D0 GB0216972 D0 GB 0216972D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- derivaties
- synuclein
- peptides
- peptide
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0216972A GB0216972D0 (en) | 2002-07-22 | 2002-07-22 | Peptides and peptide derivaties for the treatment of &-synuclein-related diseases |
PCT/GB2003/003240 WO2004009625A2 (en) | 2002-07-22 | 2003-07-22 | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES |
AU2003267532A AU2003267532A1 (en) | 2002-07-22 | 2003-07-22 | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0216972A GB0216972D0 (en) | 2002-07-22 | 2002-07-22 | Peptides and peptide derivaties for the treatment of &-synuclein-related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0216972D0 true GB0216972D0 (en) | 2002-08-28 |
Family
ID=9940894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0216972A Ceased GB0216972D0 (en) | 2002-07-22 | 2002-07-22 | Peptides and peptide derivaties for the treatment of &-synuclein-related diseases |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003267532A1 (en) |
GB (1) | GB0216972D0 (en) |
WO (1) | WO2004009625A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080014194A1 (en) | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US8697082B2 (en) | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
US7358331B2 (en) | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
WO2005047860A2 (en) | 2003-11-08 | 2005-05-26 | Elan Pharmaceuticals, Inc. | Antibodies to alpha-synuclein |
BRPI0620125B1 (en) * | 2005-12-22 | 2022-05-17 | Vrije Universiteit Brussel | Method for regulating the reduction of biological function of a protein, and method for isolating a protein from a sample |
US8147833B2 (en) | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
CA2678963C (en) | 2007-02-23 | 2018-05-01 | Elan Pharmaceuticals, Inc. | Prevention and treatment of synucleinopathic and amyloidogenic disease |
GB0716885D0 (en) * | 2007-08-30 | 2007-10-10 | United Arab Emirates Universit | Diagnostic agent |
AT506535B1 (en) | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | VACCINE CONTAINING ALPHA SYNUCLEIN MIMOTOPES BASED ON PEPTIDES |
NZ589302A (en) | 2008-04-17 | 2012-11-30 | Declion Pharmaceuticals Inc | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
WO2018005867A2 (en) * | 2016-06-29 | 2018-01-04 | The Regents Of The University Of California | Structure-based peptide inhibitors of alpha-synuclein aggregation |
CN106854233B (en) * | 2017-03-03 | 2020-07-17 | 国家纳米科学中心 | Quasi-peptide and preparation method and application thereof |
EP3946266A4 (en) * | 2019-03-28 | 2023-07-12 | The Chinese University Of Hong Kong | Sumo peptides for treating neurodegenerative diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2415179A1 (en) * | 2000-07-07 | 2002-01-17 | Panacea Pharmaceuticals, Inc. | Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
-
2002
- 2002-07-22 GB GB0216972A patent/GB0216972D0/en not_active Ceased
-
2003
- 2003-07-22 AU AU2003267532A patent/AU2003267532A1/en not_active Abandoned
- 2003-07-22 WO PCT/GB2003/003240 patent/WO2004009625A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003267532A1 (en) | 2004-02-09 |
WO2004009625A3 (en) | 2004-09-23 |
WO2004009625A2 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003239531A8 (en) | Protein cages for the delivery of medical imaging and therapy | |
HK1135330A1 (en) | Short bioactive peptides and methods for their use | |
AU2003285091A8 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
AU2003267829A8 (en) | Peptides and methods for the control of obesity | |
GB0216972D0 (en) | Peptides and peptide derivaties for the treatment of &-synuclein-related diseases | |
AU2003267124A8 (en) | Bh3 peptides and method of use thereof | |
EP1514106A4 (en) | Targeted therapeutic proteins | |
IL165998A (en) | Growth hormone releasing peptides and their use in the manufacture of medicaments | |
PL372695A1 (en) | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins | |
IL148401A0 (en) | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases | |
GB0218205D0 (en) | Human ZZAP1 protein | |
AU2003298911A8 (en) | Cyclosporins for the treatment of autoimmune diseases | |
HUP0401536A3 (en) | Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament | |
EP1362235A4 (en) | Peptide or protein microassay method and apparatus | |
SI1462455T1 (en) | Ser-Ser-Ser-Arg peptide and medicinal uses thereof | |
AU2003295343A8 (en) | Uses of human zven proteins and polynucleotides | |
IL166706A0 (en) | Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation | |
AU2003301843A8 (en) | 157 human secreted proteins | |
AU2003226899A8 (en) | Human diabetes-mediating proteins | |
GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
AU2003230144A8 (en) | Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases | |
HK1045103A1 (en) | Therapeutic uses of bpi protein products in bpi-deficient humans | |
AU2003252075A8 (en) | Human immunosuppressive protein | |
GB0201025D0 (en) | The treatment of degenerative diseases | |
AU2002364757A8 (en) | Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |